Evidence map›Paper›PMID 35875138›Full record

ArticleFrontiers in oncology2022

3D Ultrasound-Guided Photoacoustic Imaging to Monitor the Effects of Suboptimal Tyrosine Kinase Inhibitor Therapy in Pancreatic Tumors.

Abigail Claus, Allison Sweeney, Deeksha M Sankepalle, Brian Li, Daniel Wong, Marvin Xavierselvan, Srivalleesha Mallidi

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. ACS nano · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Abigail ClausDepartment of Biomedical Engineering, Tufts University, Medford, MA, United States.
Allison SweeneyDepartment of Biomedical Engineering, Tufts University, Medford, MA, United States.
Deeksha M SankepalleDepartment of Biomedical Engineering, Tufts University, Medford, MA, United States.
Brian LiDepartment of Biomedical Engineering, Tufts University, Medford, MA, United States.
Daniel WongDepartment of Biomedical Engineering, Tufts University, Medford, MA, United States.
Marvin XavierselvanDepartment of Biomedical Engineering, Tufts University, Medford, MA, United States.
Srivalleesha MallidiDepartment of Biomedical Engineering, Tufts University, Medford, MA, United States.
Tufts University · US

Funding

Ultrasound and Photoacoustic Imaging (USPAI) SystemS10OD026844 · OD · TUFTS UNIVERSITY MEDFORD · PI MALLIDI, SRIVALLEESHA · 2020 to 2020
$600k
Biodegradable liquid metal nanoagents for photoacoustic image-guided photodynamic therapyR21CA263694 · NCI · TUFTS UNIVERSITY MEDFORD · PI MALLIDI, SRIVALLEESHA · 2022 to 2023
$399k
NCI NIH HHS R21 CA263694NIH HHS S10 OD026844
6 · The paper itself

Abstract

Pancreatic cancer is a disease with an incredibly poor survival rate. As only about 20% of patients are eligible for surgical resection, neoadjuvant treatments that can relieve symptoms and shrink tumors for surgical resection become critical. Many forms of treatments rely on increased vulnerability of cancerous cells, but tumors or regions within the tumors that may be hypoxic could be drug resistant. Particularly for neoadjuvant therapies such as the tyrosine kinase inhibitors utilized to shrink tumors, it is critical to monitor changes in vascular function and hypoxia to predict treatment efficacy. Current clinical imaging modalities used to obtain structural and functional information regarding hypoxia or oxygen saturation (StO

Indexed as

blood oxygen saturationhypoxianeoadjuvant therapypancreatic cancerphotoacoustic imagingsuboptimal therapytreatment predictiontyrosine kinase inhibitor

Identifiers

PMID35875138
PMCPMC9300843
OpenAlexW4284690510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.